FMS•Fresenius Medical Care’s third-quarter 2026 net income fell 42% year over year to EUR 160 million. Revenue rose to EUR 4.94 billion, operating cash flow increased 8% to EUR 798 million, and Care Enablement posted a EUR 32 million operating loss.
Fresenius Medical Care reported third-quarter 2026 net income of EUR 160 million, down 42% year over year. Revenue rose to EUR 4.94 billion, while operating cash flow climbed 8% to EUR 798 million.
Care Enablement swung to an operating loss of EUR 32 million, mainly due to one-time costs related to refining its China strategy. The 5008X CAREsystem rollout replaced approximately 16% of U.S. clinic dialysis machines and remained on track for the 2026 target of around 20%.
